Medical foods guidance
This article was originally published in The Tan Sheet
Executive Summary
FDA's "Guidance for Industry: Frequently Asked Questions about Medical Foods" provides a definition of the category, and notes medical foods must comply with cGMPs and the Food Allergen Labeling and Consumer Protection Act of 2004. However, medical foods do not require pre-market review or approval and are exempted from the labeling requirements for health claims and nutrient content claims under the Nutrition Labeling and Education Act of 1990. The agency notes it does have a compliance program specifically for medical foods. In a November 2004 Federal Register 1notice, FDA withdrew an advance notice of proposed rulemaking on medical foods, stating its existing compliance program was a sufficient framework. The agency recently sent a warning letter to Ganeden Biotech for products labeled as medical foods that did not meet the FDA definition; however, the letter was later withdrawn (2"The Tan Sheet" March 5, 2007, In Brief)...
You may also be interested in...
Ganeden Biotech warning letter
The FDA warning letter sent to medical foods marketer Ganeden Biotech and reported in the Feb. 26 issue of "The Tan Sheet" has been removed from the agency's Web site. An FDA spokesperson told "The Tan Sheet" the letter was issued by the agency's Cincinnati office, but FDA is now in discussions with the firm over whether to withdraw the letter. The spokesperson noted that, as far as FDA is concerned, a letter was issued, and the decision to withdraw the letter was FDA's (1"The Tan Sheet" Feb. 26, 2007, In Brief)...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.